insights_auto
Why is 3164 down 2.35%?
Dive Deeperchevron_right
3164:TPE
GenMont Biotech Inc
NT$16.60
arrow_downward
-2.35%(-0.40) 1D
Nov 13, 1:30:00 PM GMT+8 · TWD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3164...
Open
NT$17.00
High
NT$17.00
Low
NT$16.50
Mkt. cap
1.43B
Avg. vol.
50.44K
Volume
38.21K
Dividend
4.82%
Quarterly dividend
NT$0.20
Ex-dividend date
Apr 8, 2026
P/E ratio
23.11
52-wk high
NT$19.75
52-wk low
NT$15.35
EPS
NT$0.72
Shares outstanding
88.91M
No. of employees
147
Open
NT$17.00
High
NT$17.00
Low
NT$16.50
Mkt. cap
1.43B
Avg. vol.
50.44K
Volume
38.21K
Dividend
4.82%
Quarterly dividend
NT$0.20
Ex-dividend date
Apr 8, 2026
P/E ratio
23.11
52-wk high
NT$19.75
52-wk low
NT$15.35
EPS
NT$0.72
Shares outstanding
88.91M
No. of employees
147
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Premarket Movers: Travelers, Palo Alto Networks Gain; Cisco, AMD Fall
Reuters
·
15 minutes ago
Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth
24/7 Wall St.
·
13 minutes ago
He Wants Anthropic in His S&P 500 401(k) as Soon as It Goes Public. One Index Rule Could Keep It Out for at Least 12 Months. Even Then, His Fund May Never Own It
FOREX.com
·
2 hours ago
S&P 500 forecast: SPX struggles for direction ahead of PPI data
About GenMont Biotech Inc